PharmaCyte Biotech, Inc.
PMCB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001157075
No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in PharmaCyte Biotech, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −1 vs. Q4 2022
- Shares held
- 3.53M
- +136.0K (+4.0%) vs. Q4 2022
- Total value
- $10.2M
- +$288.8K (+2.9%) vs. Q4 2022
- New holders
- 5
- 6 more added
- Sold out
- 6
- 8 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMCB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $586.2K |
| Q1 2026 | 36 | $643.2K |
| Q4 2025 | 30 | $712.0K |
| Q3 2025 | 25 | $419.9K |
| Q2 2025 | 25 | $632.1K |
| Q1 2025 | 26 | $709.9K |
| Q4 2024 | 23 | $934.3K |
| Q3 2024 | 29 | $1.58M |
| Q2 2024 | 32 | $2.02M |
| Q1 2024 | 33 | $2.32M |
| Q4 2023 | 36 | $2.35M |
| Q3 2023 | 34 | $2.40M |
| Q2 2023 | 32 | $3.47M |
| Q1 2023 | 33 | $10.2M |
| Q4 2022 | 34 | $9.93M |
| Q3 2022 | 33 | $12.0M |
| Q2 2022 | 35 | $8.79M |
| Q1 2022 | 28 | $8.83M |
| Q4 2021 | 30 | $8.68M |
| Q3 2021 | 24 | $4.42M |
| Q2 2021 | 5 | $5.43K |
| Q1 2021 | 5 | $8.68K |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding PharmaCyte Biotech, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Huntington National Bank | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 98 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 2 | $6 | 0.00% | 00.0% | Unchanged |
| Carolina Wealth Advisors, LLC | 2 | $6 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 3 | $9 | 0.00% | 00.0% | Unchanged |
| Anchor Investment Management, LLC | 27 | $79 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 31 | $90 | 0.00% | −24−43.6% | Reduced |
| Bank of America Corp | 54 | $157 | 0.00% | −44−44.9% | Reduced |
| Advisory Services Network, LLC | 67 | $195 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 129 | $375 | 0.00% | −12−8.5% | Reduced |
| Kelly Financial Services LLC | 234 | $681 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 505 | $1.00K | 0.00% | +298+144.0% | Added |
| Aspire Private Capital, LLC | 800 | $2.33K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,688 | $4.91K | 0.00% | +1,679+18,655.6% | Added |
| Advisor Group Holdings, Inc. | 1,758 | $5.12K | 0.00% | 00.0% | Unchanged |
| Belvedere Trading LLC | 7,135 | $20.8K | 0.01% | +7,135 | New |
| Acadian Asset Management LLC | 9,264 | $26.0K | 0.00% | +9,264 | New |
| Group One Trading, L.P. | 14,382 | $41.9K | 0.00% | +14,382 | New |
| Schonfeld Strategic Advisors LLC | 24,000 | $69.8K | 0.00% | −1,200−4.8% | Reduced |
| Price T Rowe Associates Inc | 25,600 | $75.0K | 0.00% | −10,800−29.7% | Reduced |
| Northern Trust Corp | 29,248 | $85.1K | 0.00% | −8,371−22.3% | Reduced |
| Dimensional Fund Advisors LP | 29,303 | $85.3K | 0.00% | +29,303 | New |
| BlackRock Inc. | 43,711 | $127.2K | 0.00% | +31,727+264.7% | Added |
| State Street Corp | 62,600 | $182.2K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 76,011 | $221.2K | 0.00% | +58,508+334.3% | Added |
| Susquehanna International Group, LLP | 106,886 | $311.0K | 0.00% | +106,886 | New |
| Simplex Trading, LLC | 133,200 | $387.0K | 0.02% | +69,592+109.4% | Added |
| Geode Capital Management, LLC | 175,264 | $510.0K | 0.00% | 00.0% | Unchanged |
| Equitec Proprietary Markets, LLC | 330,694 | $962.3K | 0.91% | 00.0% | Unchanged |
| Vanguard Group Inc | 701,450 | $2.04M | 0.00% | +46,933+7.2% | Added |
| K2 Principal Fund, L.P. | 723,271 | $2.06M | 0.57% | −8,834−1.2% | Reduced |
| Ayrton Capital LLC | 1,030,530 | $3.00M | 10.77% | −2,600−0.3% | Reduced |
| Sabby Management, LLC | 0 | $0 | 0.00% | −97,978−100.0% | Sold out |
| Davy Global Fund Management Ltd | 0 | $0 | 0.00% | −40,800−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −31,100−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −20,705−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −17,219−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |